Bergwerk Dov — SEC insider filings
SEC reporting owner CIK 1997381. 6 insider filings on record with FilingPulse; latest filed 2026-11-17.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2023-11-16 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 26,260 shares, $1,095,567 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 17,505 shares @ $41.72 ($730,309) in TEVA PHARMACEUTICAL INDUSTRIES LTD, filed 2026-11-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Interim Chief Legal Officer | 6 | — | 2 legs · 26,260 sh · $1,095,567 | 10 |
Insider filings — Bergwerk Dov
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-17 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 8,370 · Option exercise (M): 8,370 (derivative) @ $0 | EDGAR |
| 2026-11-12 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 9,433 (derivative) @ $0 | EDGAR |
| 2026-11-06 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 17,505 @ $34.70 · Sale (S): 17,505 @ $41.72 · Option exercise (M): 8,755 @ $28.98 · Sale (S): 8,755 @ $41.72 · Option exercise (M): 17,505 (derivative) @ $0 · Option exercise (M): 8,755 (derivative) @ $0 | EDGAR |
| 2026-10-08 | 3 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Holdings only — no transactions reported | EDGAR |
| 2024-03-01 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Option exercise (M): 6,653 · Option exercise (M): 6,653 (derivative) @ $0 | EDGAR |
| 2023-11-16 | 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Grant/award (A): 33,482 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1997381 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs